Form 4 for MAZE Maze Therapeutics, Inc.
Accepted 2026-09-03 16:27:42 ET · period of report 2026-09-01 · accession 0001676170-26-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMTI | 2026-09-03 16:27 | 2026-09-01 | MAZE | Coloma Jason V | CEO, Dir | S - Sale+OE | $26.29 | -34.5K | 223.4K | -13% | -$907.0K |
| DT | 2026-09-03 16:27 | 2026-09-01 | MAZE | Coloma Jason V | CEO, Dir | M - OptEx | $0.00 | +50.0K | 50.0K | New | $0 |
| DT | 2026-09-03 16:27 | 2026-09-01 | MAZE | Coloma Jason V | CEO, Dir | M - OptEx | $0.00 | -50.0K | 50.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | S | D | 2,593 | $26.31 | 18,151 | I The Coloma 2021 Irrevocable Trust | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.14 to $26.50 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 4 of this Form 4. (F3) These securities are directly held by The Coloma 2021 Irrevocable Trust, for which the reporting person and his spouse serve as co-trustees. |
| 2 | Common | Common Stock | 2026-09-01 | S | D | 31,908 | $26.29 | 223,355 | I Coloma Family Trust | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. (F4) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.13 to $26.555 per share, inclusive. (F5) These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees. |
| 3 | Common | Common Stock | 2026-09-01 | M | A | 50,000 | $0.00 | 50,000 | D | — | — | |
| 4 | Derivative | Restricted Stock Units | 2026-09-01 | M | D | 50,000 | $0.00 | 50,000 | D | — · — to — | 50,000 Common Stock | (F6) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. (F7) The award vested or vests as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date. (F8) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |